This resource is a fact sheet about buprenorphine-naloxone (Suboxone) used by Oregon Health & Science University’s Improving Addiction Care Team (IMPACT). Continue reading
Resource Tag: Medication Assisted Treatment
Medication assisted treatment
Methandone
Buprenorphine
Naltrexone
Vivitrol
Opioid treatment program (OTP)
Office based opioid treatment (OBOT)
Drug Addiction Treatment Act (DATA) waiver
Improving Addiction Care Team (IMPACT): Medication Procedures, Alternatives, Risks and Questions
This document serves as a template for conducting informed consent (also known as PARQs – procedures, alternatives, risks and questions) for patients beginning medication assisted treatment with buprenorphine or naltrexone. Continue reading
Improving Addiction Care Team (IMPACT): OHSU Practice Recommendations for the Perioperative Management of Patients on Buprenorphine-Containing Drugs
This resource captures Oregon Health & Science University’s practice recommendations for the management of pain in patients on buprenorphine undergoing surgery and pregnant women during labor, delivery, and the post-partum period. Continue reading
Improving Addiction Care Team (IMPACT): OHSU Pharmacy and Therapeutics Policy on use of Medication to Treat Opioid Use Disorder (Pregnant and Non-Pregnant Patients)
This resource is Oregon Health & Science University’s pharmacy and therapeutics policy on the use of medications (methadone, buprenorphine, and naltrexone) for opioid withdrawal management or opioid maintenance therapy in patients with opioid use disorder who are hospitalized or seen in the emergency department. Continue reading
Improving Addiction Care Team (IMPACT): Medications to Treat Substance use Disorders
This resource serves as a guide to beginning medication assisted treatment for individuals with opioid use disorder or alcohol use disorder in the hospital setting. It is one of the protocols and tools developed for Oregon Health & Science University’s Improving Addiction Care Team (IMPACT) program, which provides addiction medicine consultations to patients treated in the hospital who have a diagnosis of substance use disorder. Continue reading
Provider Implementation Guide Using a Medication First Model
The Missouri Department of Mental Health (DMH) created this provider implementation guide for their Medication First opioid use disorder treatment model. The Medication First treatment model was developed by DMH staff with assistance from staff from the Missouri Institute of Mental Health at the University of Missouri, St. Louis, and is based on the successful Housing First model used to address homelessness. Continue reading
Evidence Brief: Barriers and Facilitators to Use of Medications for Opioid Use Disorder
A review of studies on barriers or facilitators to use of medication assisted treatment (MAT) for opioid use disorder (OUD) from the Veteran’s Health Administrations Evidence Synthesis Program. The use of MAT to treat OUD is an evidence-based practice that is often not implemented in real world settings. Continue reading
Spotlight: Yale Emergency Department Treatment Initiation
A brief overview of the emergency department (ED) based induction to buprenorphine program initiated at Yale New Haven Hospital. This report describes a randomized controlled trial that provided patients with opioid use disorder seen in the emergency room with either a substance use disorder screening and referral to treatment, a screening and brief intervention with facilitated referral to treatment, or induction to buprenorphine medicated assisted treatment and a referral to follow up treatment. Those patients offered buprenorphine were significantly more likely to be engaged in treatment 30 days later than the other patients. This model has subsequently been adopted in EDs across the country. This report is part of the Addiction Policy Forum’s Spotlight series which highlights innovative programs to address the opioid crisis. Continue reading
Medication Assisted Treatment – Law Enforcement, Corrections and Justice Settings
The use of medication assisted treatment (MAT) has increasingly been adopted in justice settings including correctional facilities, re-entry programs, and treatment courts. This collection includes:
- An 11 minute video featuring the stories of individuals who achieved recovery from addiction through receiving medication-assisted treatment (MAT) while in jail
- A comprehensive toolkit from the National Council on Behavioral Health and Vital Strategies to guide correctional staff in creating and managing medication assisted treatment programs for individuals with opioid use disorder in jails and prisons
- A 2019 overview from the Substance Abuse and Mental Health Services Administration of MAT in criminal justice settings
- A 2019 report from the O’Neill Institute for Global Health Law on legal, legislative and fiscal strategies to implement MAT in correctional facilities, treatment courts and the child welfare system
- A report from the National Sheriff’s Association and the National Commission on Correctional Health Care on implementing MAT programs in the jail setting
- A guide from the Substance Abuse and Mental Health Services and Bureau of Justice Assistance to preventing and addressing medication diversion for medication assisted treatment (MAT) programs in correctional facilities
- A report from the Legal Action Center on MAT in treatment courts
- A report from the National Judicial Opioid Task Force on MAT for youth and young adults with justice-involvement
- An overview from the National Judicial Opioid Task Force of MAT in criminal justice settings
- A report from the National Judicial Opioid Task Force describing promising strategies for increasing access to MAT in rural areas
Continue reading
Medication Assisted Treatment – Hospitals and Emergency Departments
Hospital inpatient care programs and emergency departments are increasingly developing policies and programs to provide medication assisted treatment (MAT) to their patients. This collection features guidelines from the Massachusetts Health & Hospital Association, resources and tools from the California American College of Emergency Physicians, and links to the Public Health Institute’s California Bridge Program and the California Health Care Foundation’s Support for Hospital Opioid Use Treatment (SHOUT) initiative. Also included is a link to Massachusetts General Hospital’s “Get Waivered” campaign which provides free buprenorpine waiver training and support for creating emergency department programs.